Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Gimeracil is an inhibitor of dihydropyrimidine dehydrogenase (DYPD; Ki = 0.36 µM), the rate limiting enzyme in the catabolism of pyrimidines, including 5-fluorouracil (5-FU; Item No. 14416).1 It inhibits the degradation of 5-FU in rat liver extracts (IC50 = 0.1 µM). Gimeracil inhibits homologous recombination and enhances radiation-induced cell death in DLD-1 human colorectal cancer cells.2 Formulations containing gimeracil have been used in conjunction with 5-fluorouracil in the treatment of various cancers.
WARNING This product is not for human or veterinary use.
1. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-
2. Gimeracil, an inhibitor of dihydropyrimidine dehydrogenase, inhibits the early step in homologous recombination. Cancer Sci. 102(9), 1712-1716 (2011).